192 related articles for article (PubMed ID: 24365054)
1. Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy.
Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
Virol J; 2013 Dec; 10():360. PubMed ID: 24365054
[TBL] [Abstract][Full Text] [Related]
2. LGL leukemia and HTLV.
Thomas A; Perzova R; Abbott L; Benz P; Poiesz MJ; Dube S; Loughran T; Ferrer J; Sheremata W; Glaser J; Leon-Ponte M; Poiesz BJ
AIDS Res Hum Retroviruses; 2010 Jan; 26(1):33-40. PubMed ID: 20047475
[TBL] [Abstract][Full Text] [Related]
3. Increased seroreactivity to human T cell lymphoma/leukemia virus-related endogenous sequence-1 Gag peptides in patients with human T cell lymphoma/leukemia virus myelopathy.
Perzova R; Graziano E; Sanghi S; Welch C; Benz P; Abbott L; Lalone D; Glaser J; Loughran T; Sheremata W; Poiesz BJ
AIDS Res Hum Retroviruses; 2015 Feb; 31(2):242-9. PubMed ID: 25295378
[TBL] [Abstract][Full Text] [Related]
4. Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.
Jones RB; Leal FE; Hasenkrug AM; Segurado AC; Nixon DF; Ostrowski MA; Kallas EG
J Negat Results Biomed; 2013 Jan; 12():3. PubMed ID: 23305161
[TBL] [Abstract][Full Text] [Related]
5. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.
Mahieux R; Horal P; Mauclère P; Mercereau-Puijalon O; Guillotte M; Meertens L; Murphy E; Gessain A
J Clin Microbiol; 2000 Nov; 38(11):4049-57. PubMed ID: 11060067
[TBL] [Abstract][Full Text] [Related]
6. Type- and group-specific continuous antigenic determinants of HTLV. Use of synthetic peptides for serotyping of HTLV-I and -II infection.
Blomberg J; Robert-Guroff M; Blattner WA; Pipkorn R
J Acquir Immune Defic Syndr (1988); 1992; 5(3):294-302. PubMed ID: 1371319
[TBL] [Abstract][Full Text] [Related]
7. Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators.
Toufaily C; Landry S; Leib-Mosch C; Rassart E; Barbeau B
Viruses; 2011 Nov; 3(11):2146-59. PubMed ID: 22163338
[TBL] [Abstract][Full Text] [Related]
8. HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators.
Murphy EL; Fridey J; Smith JW; Engstrom J; Sacher RA; Miller K; Gibble J; Stevens J; Thomson R; Hansma D; Kaplan J; Khabbaz R; Nemo G
Neurology; 1997 Feb; 48(2):315-20. PubMed ID: 9040713
[TBL] [Abstract][Full Text] [Related]
9. Characterization of immunodominant epitopes of gag and pol gene-encoded proteins of human T-cell lymphotropic virus type I.
Lal RB; Rudolph DL; Griffis KP; Kitamura K; Honda M; Coligan JE; Folks TM
J Virol; 1991 Apr; 65(4):1870-6. PubMed ID: 2002547
[TBL] [Abstract][Full Text] [Related]
10. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
11. Serological speciation of human T-cell leukaemia virus infections using synthetic peptide antigens.
Tosswill JH; McAlpine L; Mortimer PP
J Med Virol; 1993 May; 40(1):83-5. PubMed ID: 8099946
[TBL] [Abstract][Full Text] [Related]
12. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy.
Kitze B; Usuku K; Izumo S; Nakamura M; Shiraki H; Ijichi S; Yashiki S; Fujiyoshi T; Sonoda S; Osame M
J Neurol; 1996 May; 243(5):393-400. PubMed ID: 8741079
[TBL] [Abstract][Full Text] [Related]
13. Human T-cell lymphotropic virus type II-associated myelopathy: clinical and immunologic profiles.
Lehky TJ; Flerlage N; Katz D; Houff S; Hall WH; Ishii K; Monken C; Dhib-Jalbut S; McFarland HF; Jacobson S
Ann Neurol; 1996 Nov; 40(5):714-23. PubMed ID: 8957012
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and significance of HTLV-I/II seroindeterminate Western blot patterns.
Abrams A; Akahata Y; Jacobson S
Viruses; 2011 Aug; 3(8):1320-31. PubMed ID: 21994781
[TBL] [Abstract][Full Text] [Related]
15. Evidence of serological cross-reactivities with human immunodeficiency virus types 1 and 2 and human T-lymphotropic virus types I and II in sera of pregnant women in Ibadan, Nigeria.
Olaleye DO; Ekweozor CC; Sheng Z; Rasheed S
Int J Epidemiol; 1995 Feb; 24(1):198-203. PubMed ID: 7797344
[TBL] [Abstract][Full Text] [Related]
16. Different B-cell responses to human T-cell lymphotropic virus type I (HTLV-I) envelope synthetic peptides in HTLV-I-infected individuals.
Ida H; Kurata A; Eguchi K; Kawakami A; Migita K; Fukuda T; Nakamura T; Kusumoto Y; Berzofsky JA; Nagataki S
J Clin Immunol; 1991 May; 11(3):143-51. PubMed ID: 1890164
[TBL] [Abstract][Full Text] [Related]
17. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile.
Barrientos A; Lopez M; Sotomayor C; Pilleux L; Calderón S; Navarrete M; Otth C
J Med Virol; 2011 Apr; 83(4):745-8. PubMed ID: 21328393
[TBL] [Abstract][Full Text] [Related]
19. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
[TBL] [Abstract][Full Text] [Related]
20. Prototypical HTLV-I/II infection is rare in LGL leukemia.
Loughran TP; Sherman MP; Ruscetti FW; Frey S; Coyle T; Montagna RA; Jones B; Starkebaum G; Poiesz BJ
Leuk Res; 1994 Jun; 18(6):423-9. PubMed ID: 8207960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
